Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Proteomics. 2015 Nov 24;16(1):33–46. doi: 10.1002/pmic.201500171

Table 3. Proteins upregulated with VEGF inhibitor treatment and associated with each of the enriched antifibrotic pathways.

Antifibrotic enriched pathways Proteins upregulated with VEGF inhibitor treatment
Natural killer cell signaling PAK6, SOS1, SH3BP2, INPP5D
PTEN signaling FLT1, SOS1, KDR, INPP5D
Intrinsic prothrombin activation pathway FGG, COL3A1
Gap junction signaling SOS1, PLCD4, HTR2A, MAP3K2
Endothelin-1 signaling RIPK1, SOS1, MAP3K2